Skip to content

Evaluation of the proper use of traditional Chinese medicine for subjects with knee joint pain and chronic muscular pain

Evaluation of the proper use of traditional Chinese medicine for subjects with knee joint pain and chronic muscular pain - Evaluation of the proper use of traditional Chinese medicine for subjects with knee joint pain and chronic muscular pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000005863
Enrollment
16
Registered
2011-06-28
Start date
2011-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee joint pain Chronic muscular pain

Interventions

Traditional Chinese medicine

Sponsors

Tana orthopedic surgery
Lead Sponsor
Kitashinyokohama orthopedic surgery
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Subjects from 40 to 74 years old 2) Knee joint pain with more than 20mm/100mm at VAS scale 3) Kellgren-Lawrence grade 0–III (mainly K/L grade 0-II) 4) Chronic muscular pain (neck stiffness)

Exclusion criteria

Exclusion criteria: 1) Other joint pain 2) 30 score on JOA (pain, walking ability) 3) Hyperuricemia, gouty attack 4) Positive rheumatoid factor 5) Knee joint surgery 6) Hyaluronic acid, glucosamine, chondroitin sulfate 7) Treated with medicine for knee join pain and chronic muscular pain 8) Bisphosphonate, hormonal therapy 9) Joint injection with hyaluronic acid or steroid 10) Occasional strenuous exercise 11) Bone disorders 12) Allergic 13) Malignant tumor, severe hypertension, heart disease, renal dysfunction, thyroid dysfunction, liver disease 14) Lactating, pregnant 15) Swelling 16) Treated with Chinese medicine 17) Treated with herbal medicine 18) Treated with sympathomimetic agent 19) Treated with medicine promoting reduction of levels of potassium in blood 20) Without ability of agreement or complaining 21) Alcoholism 22) Judged as unsuitable for this study based on the results of questionnaire 23) Judged as unsuitable for this study based on the results of clinical examination 24) 200 mL of blood donation 25) BMI of more than 35 26) Participant of other clinical trials 27) Judged as unsuitable for this study by the doctor

Design outcomes

Primary

MeasureTime frame
JKOM JOA VAS

Secondary

MeasureTime frame
Biomarker Muscular rigidity Blood flow Endothelial function

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026